Quarterly report pursuant to Section 13 or 15(d)

INVESTMENTS AND OTHER ASSETS (Details)

v3.21.2
INVESTMENTS AND OTHER ASSETS (Details)
$ / shares in Units, $ in Thousands
3 Months Ended 9 Months Ended
Oct. 28, 2021
shares
Jun. 30, 2021
USD ($)
a
shares
Dec. 03, 2019
USD ($)
item
$ / shares
Jun. 30, 2020
USD ($)
Sep. 30, 2021
USD ($)
shares
Sep. 30, 2020
USD ($)
Dec. 31, 2020
USD ($)
Marketable Securities [Line Items]              
Long-term Investments         $ 7,300   $ 6,536
Note receivable         3,713   5,876
Impairment of Panacea investment           $ 1,062  
Gain on Panacea investment conversion         2,548    
Subsequent Event [Member] | Exactus [Member]              
Marketable Securities [Line Items]              
Reverse stock split, ratio 0.035714            
Investment in Panacea              
Marketable Securities [Line Items]              
Long-term Investments     $ 13,297        
Amount paid to acquire investments     $ 12,000        
Shares issued in purchase, value per share | $ / shares     $ 1        
Shares issued for Panacea, value     $ 1,297        
Ownership percentage (in percent)     15.80%        
Number of instruments comprising the investment | item     3        
Note receivable   $ 3,684          
Exercise price | $ / shares     $ 2.344        
Note receivable, face amount   $ 4,300 $ 7,000        
Note receivable term     5 years        
Note receivable interest rate   0.00% 10.00%        
Dividend rate     10.00%        
Number of years for acceleration of exercise date     2 years        
Area of Land | a   224          
Gain on Panacea investment conversion   $ 2,548          
Panacea conversion assets included in acquisition of property, plant and equipment   2,248          
Stock received in conversion, value   500          
Note receivable, discount   616          
Investment in Panacea | Preferred stock              
Marketable Securities [Line Items]              
Long-term Investments             5,173
Investment in Panacea | Warrant              
Marketable Securities [Line Items]              
Long-term Investments             $ 1,124
Ownership percentage (in percent)     51.00%        
Impairment of Panacea investment       $ 1,062      
Investment in Panacea | Warrant | Volatility              
Marketable Securities [Line Items]              
Warrants measurement input     0.70        
Investment in Panacea | Warrant | Discount for lack of marketability              
Marketable Securities [Line Items]              
Warrants measurement input     0.25        
Investment in Panacea | Warrant | Risk-free rate              
Marketable Securities [Line Items]              
Warrants measurement input     0.02        
Exactus [Member]              
Marketable Securities [Line Items]              
Long-term Investments   $ 9,102     $ 7,282    
Stock received in conversion, shares | shares   91,016,026          
Number of shares held in investee | shares         91,016,026    
Exactus [Member] | Subsequent Event [Member]              
Marketable Securities [Line Items]              
Number of shares held in investee | shares 3,250,573